Christian Hopfer
Concepts (401)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance-Related Disorders | 36 | 2023 | 951 | 4.040 |
Why?
| Marijuana Abuse | 21 | 2024 | 208 | 3.900 |
Why?
| Cannabis | 11 | 2024 | 381 | 3.210 |
Why?
| Conduct Disorder | 16 | 2023 | 193 | 2.270 |
Why?
| Marijuana Use | 7 | 2024 | 164 | 1.700 |
Why?
| Adolescent Behavior | 16 | 2020 | 480 | 1.620 |
Why?
| Alcohol Drinking | 15 | 2024 | 653 | 1.530 |
Why?
| Marijuana Smoking | 9 | 2022 | 224 | 1.490 |
Why?
| Alcoholism | 17 | 2020 | 715 | 1.280 |
Why?
| Social Environment | 10 | 2014 | 287 | 1.250 |
Why?
| Tobacco Use Disorder | 11 | 2020 | 237 | 1.210 |
Why?
| Adolescent | 90 | 2024 | 17935 | 1.210 |
Why?
| Polymorphism, Single Nucleotide | 21 | 2022 | 2004 | 1.150 |
Why?
| Antisocial Personality Disorder | 15 | 2018 | 159 | 1.150 |
Why?
| Genetic Predisposition to Disease | 16 | 2022 | 2201 | 1.050 |
Why?
| Twins | 9 | 2024 | 240 | 0.870 |
Why?
| Medical Marijuana | 3 | 2020 | 97 | 0.840 |
Why?
| Siblings | 12 | 2020 | 223 | 0.840 |
Why?
| Analgesics, Opioid | 6 | 2020 | 783 | 0.790 |
Why?
| Smoking | 16 | 2019 | 1465 | 0.780 |
Why?
| Risk-Taking | 7 | 2019 | 332 | 0.760 |
Why?
| Genome-Wide Association Study | 14 | 2022 | 1277 | 0.760 |
Why?
| Dronabinol | 2 | 2020 | 118 | 0.760 |
Why?
| Young Adult | 36 | 2023 | 10508 | 0.750 |
Why?
| Female | 92 | 2023 | 60070 | 0.730 |
Why?
| Male | 91 | 2023 | 56103 | 0.730 |
Why?
| Humans | 121 | 2024 | 115859 | 0.720 |
Why?
| Opioid-Related Disorders | 5 | 2021 | 422 | 0.710 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 10 | 2018 | 230 | 0.710 |
Why?
| Colorado | 23 | 2022 | 4122 | 0.710 |
Why?
| Problem Behavior | 2 | 2018 | 86 | 0.700 |
Why?
| Legislation, Drug | 3 | 2022 | 73 | 0.690 |
Why?
| Cannabinol | 1 | 2019 | 2 | 0.670 |
Why?
| Diseases in Twins | 4 | 2014 | 175 | 0.650 |
Why?
| Hallucinogens | 1 | 2020 | 73 | 0.650 |
Why?
| Adult | 56 | 2024 | 30814 | 0.640 |
Why?
| Homeless Youth | 3 | 2008 | 15 | 0.640 |
Why?
| Mental Disorders | 8 | 2021 | 903 | 0.620 |
Why?
| Criminals | 1 | 2018 | 29 | 0.620 |
Why?
| Substance Abuse, Intravenous | 3 | 2016 | 99 | 0.610 |
Why?
| Colitis, Ulcerative | 1 | 2019 | 106 | 0.600 |
Why?
| Sexual Behavior | 5 | 2019 | 440 | 0.590 |
Why?
| Prescription Drug Misuse | 1 | 2017 | 38 | 0.580 |
Why?
| Cigarette Smoking | 1 | 2018 | 80 | 0.580 |
Why?
| Longitudinal Studies | 24 | 2024 | 2416 | 0.580 |
Why?
| Receptors, Nicotinic | 7 | 2016 | 275 | 0.570 |
Why?
| Prevalence | 11 | 2022 | 2270 | 0.560 |
Why?
| Genetic Linkage | 3 | 2008 | 314 | 0.540 |
Why?
| Prescription Drug Diversion | 1 | 2016 | 12 | 0.530 |
Why?
| Crohn Disease | 1 | 2019 | 197 | 0.520 |
Why?
| Genotype | 15 | 2019 | 1830 | 0.500 |
Why?
| Motivation | 2 | 2018 | 496 | 0.490 |
Why?
| Body Mass Index | 3 | 2018 | 1974 | 0.470 |
Why?
| Accidents, Traffic | 2 | 2018 | 170 | 0.460 |
Why?
| Inflammatory Bowel Diseases | 1 | 2018 | 289 | 0.460 |
Why?
| Receptors, Dopamine D2 | 4 | 2007 | 85 | 0.450 |
Why?
| Family Health | 1 | 2014 | 199 | 0.430 |
Why?
| Polymorphism, Genetic | 4 | 2016 | 633 | 0.410 |
Why?
| Genetic Variation | 5 | 2022 | 893 | 0.410 |
Why?
| Heroin Dependence | 2 | 2003 | 22 | 0.400 |
Why?
| Phenotype | 14 | 2020 | 2859 | 0.360 |
Why?
| Child Abuse | 6 | 2021 | 455 | 0.360 |
Why?
| Urban Population | 2 | 2012 | 405 | 0.350 |
Why?
| Prospective Studies | 9 | 2020 | 6276 | 0.350 |
Why?
| Substance Abuse Detection | 2 | 2020 | 62 | 0.350 |
Why?
| Surveys and Questionnaires | 12 | 2019 | 4673 | 0.340 |
Why?
| Impulsive Behavior | 4 | 2017 | 110 | 0.340 |
Why?
| United States | 17 | 2022 | 12319 | 0.340 |
Why?
| Biological Specimen Banks | 4 | 2019 | 101 | 0.340 |
Why?
| Nurses, Community Health | 2 | 2019 | 32 | 0.340 |
Why?
| Substance Withdrawal Syndrome | 2 | 2019 | 159 | 0.330 |
Why?
| United Kingdom | 3 | 2019 | 230 | 0.330 |
Why?
| Prenatal Care | 3 | 2019 | 257 | 0.320 |
Why?
| Criminal Behavior | 2 | 2018 | 6 | 0.320 |
Why?
| Comorbidity | 8 | 2016 | 1476 | 0.320 |
Why?
| Attention Deficit Disorder with Hyperactivity | 5 | 2022 | 362 | 0.310 |
Why?
| Haplotypes | 5 | 2009 | 475 | 0.310 |
Why?
| Cognition | 4 | 2020 | 980 | 0.310 |
Why?
| House Calls | 2 | 2019 | 131 | 0.310 |
Why?
| Sex Factors | 10 | 2017 | 1741 | 0.300 |
Why?
| Adolescent Development | 2 | 2019 | 84 | 0.300 |
Why?
| Genetic Association Studies | 4 | 2021 | 352 | 0.290 |
Why?
| Case-Control Studies | 10 | 2019 | 3054 | 0.290 |
Why?
| Health Surveys | 5 | 2012 | 447 | 0.290 |
Why?
| Receptors, Cannabinoid | 1 | 2006 | 14 | 0.290 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2006 | 43 | 0.280 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2006 | 49 | 0.280 |
Why?
| Multifactorial Inheritance | 3 | 2022 | 128 | 0.280 |
Why?
| Analgesics | 2 | 2020 | 157 | 0.280 |
Why?
| Cross-Sectional Studies | 8 | 2018 | 4447 | 0.280 |
Why?
| Home Care Services | 2 | 2019 | 226 | 0.280 |
Why?
| Tandem Mass Spectrometry | 2 | 2020 | 414 | 0.280 |
Why?
| Multigene Family | 3 | 2013 | 198 | 0.270 |
Why?
| Mothers | 3 | 2019 | 666 | 0.270 |
Why?
| Drug Prescriptions | 2 | 2018 | 241 | 0.270 |
Why?
| Registries | 1 | 2014 | 1772 | 0.270 |
Why?
| Homosexuality | 1 | 2006 | 16 | 0.270 |
Why?
| Bisexuality | 1 | 2006 | 17 | 0.270 |
Why?
| Receptors, Dopamine D1 | 1 | 2006 | 25 | 0.270 |
Why?
| Tobacco Use | 2 | 2024 | 61 | 0.260 |
Why?
| Juvenile Delinquency | 4 | 2018 | 103 | 0.260 |
Why?
| Aggression | 4 | 2022 | 185 | 0.250 |
Why?
| Research Subjects | 2 | 2015 | 40 | 0.250 |
Why?
| Genomics | 3 | 2020 | 653 | 0.240 |
Why?
| Obesity | 1 | 2017 | 2523 | 0.240 |
Why?
| Substance Abuse Treatment Centers | 3 | 2012 | 43 | 0.240 |
Why?
| Genome | 1 | 2006 | 274 | 0.240 |
Why?
| Linkage Disequilibrium | 7 | 2021 | 268 | 0.240 |
Why?
| Child Behavior Disorders | 3 | 2011 | 128 | 0.240 |
Why?
| Age of Onset | 5 | 2018 | 455 | 0.230 |
Why?
| Internationality | 2 | 2022 | 147 | 0.230 |
Why?
| Alleles | 8 | 2018 | 817 | 0.230 |
Why?
| Interview, Psychological | 4 | 2013 | 91 | 0.220 |
Why?
| Genetic Loci | 3 | 2022 | 280 | 0.220 |
Why?
| Adoption | 1 | 2003 | 38 | 0.220 |
Why?
| Child | 22 | 2022 | 18537 | 0.220 |
Why?
| Heroin | 1 | 2003 | 23 | 0.220 |
Why?
| Gene Frequency | 6 | 2016 | 506 | 0.220 |
Why?
| Narcotics | 1 | 2003 | 45 | 0.220 |
Why?
| Nerve Tissue Proteins | 5 | 2013 | 537 | 0.210 |
Why?
| Models, Genetic | 6 | 2010 | 579 | 0.210 |
Why?
| Incidence | 4 | 2018 | 2336 | 0.200 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 72 | 0.200 |
Why?
| Risk Factors | 11 | 2022 | 8715 | 0.200 |
Why?
| Age Factors | 6 | 2014 | 2911 | 0.200 |
Why?
| Public Health | 1 | 2006 | 438 | 0.190 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 57 | 0.190 |
Why?
| Cannabinoid Receptor Agonists | 1 | 2020 | 30 | 0.180 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 116 | 0.180 |
Why?
| Twins, Monozygotic | 4 | 2010 | 210 | 0.180 |
Why?
| Depression | 3 | 2022 | 1145 | 0.180 |
Why?
| Pain, Postoperative | 2 | 2019 | 195 | 0.180 |
Why?
| Monoamine Oxidase | 2 | 2013 | 27 | 0.170 |
Why?
| Autistic Disorder | 1 | 2022 | 163 | 0.170 |
Why?
| Health Risk Behaviors | 1 | 2019 | 13 | 0.170 |
Why?
| Nausea | 1 | 2020 | 103 | 0.170 |
Why?
| Maternal Health | 1 | 2019 | 44 | 0.170 |
Why?
| Behavior, Addictive | 1 | 2020 | 78 | 0.170 |
Why?
| HIV Infections | 1 | 2013 | 2471 | 0.170 |
Why?
| Physician Incentive Plans | 1 | 2018 | 6 | 0.160 |
Why?
| Minisatellite Repeats | 1 | 2019 | 39 | 0.160 |
Why?
| Expressed Emotion | 1 | 2018 | 18 | 0.160 |
Why?
| Multimodal Imaging | 1 | 2019 | 98 | 0.160 |
Why?
| Pregnancy | 5 | 2022 | 5555 | 0.160 |
Why?
| Mortality, Premature | 1 | 2018 | 11 | 0.160 |
Why?
| Calcium-Transporting ATPases | 1 | 2018 | 35 | 0.160 |
Why?
| Chromatography, Liquid | 1 | 2020 | 346 | 0.160 |
Why?
| Digestive System Surgical Procedures | 1 | 2019 | 89 | 0.160 |
Why?
| Feeding and Eating Disorders | 1 | 2020 | 119 | 0.160 |
Why?
| Cannabinoids | 2 | 2017 | 116 | 0.150 |
Why?
| Suicide | 2 | 2021 | 501 | 0.150 |
Why?
| Biomedical Research | 2 | 2014 | 589 | 0.150 |
Why?
| Middle Aged | 11 | 2019 | 27078 | 0.150 |
Why?
| Analgesics, Non-Narcotic | 1 | 2019 | 117 | 0.150 |
Why?
| Urine | 1 | 2017 | 56 | 0.150 |
Why?
| Infant, Newborn | 4 | 2020 | 5084 | 0.150 |
Why?
| Receptors, Opioid, mu | 2 | 2015 | 52 | 0.150 |
Why?
| Bioethics | 1 | 2017 | 13 | 0.150 |
Why?
| Neuropsychological Tests | 2 | 2020 | 918 | 0.150 |
Why?
| Unsafe Sex | 2 | 2016 | 58 | 0.140 |
Why?
| Physicians, Family | 1 | 2018 | 202 | 0.140 |
Why?
| Counseling | 1 | 2020 | 346 | 0.140 |
Why?
| Brain | 2 | 2019 | 2372 | 0.140 |
Why?
| Depressive Disorder, Major | 2 | 2020 | 304 | 0.140 |
Why?
| Administration, Oral | 1 | 2019 | 733 | 0.140 |
Why?
| Gene-Environment Interaction | 2 | 2020 | 185 | 0.140 |
Why?
| Mental Health | 1 | 2022 | 571 | 0.140 |
Why?
| Lipids | 1 | 2020 | 589 | 0.140 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2016 | 35 | 0.140 |
Why?
| Self Report | 2 | 2018 | 700 | 0.130 |
Why?
| Patient Admission | 2 | 2012 | 175 | 0.130 |
Why?
| Drug Storage | 1 | 2016 | 58 | 0.130 |
Why?
| Mental Competency | 1 | 2015 | 25 | 0.130 |
Why?
| Brain Mapping | 1 | 2019 | 521 | 0.130 |
Why?
| Plasma | 1 | 2017 | 213 | 0.130 |
Why?
| Interviews as Topic | 3 | 2007 | 595 | 0.130 |
Why?
| Surgical Procedures, Operative | 1 | 2018 | 210 | 0.130 |
Why?
| Drug Overdose | 2 | 2018 | 295 | 0.130 |
Why?
| Image Processing, Computer-Assisted | 1 | 2019 | 690 | 0.130 |
Why?
| Neuroimaging | 1 | 2017 | 248 | 0.120 |
Why?
| Life Change Events | 1 | 2016 | 135 | 0.120 |
Why?
| Exploratory Behavior | 2 | 2013 | 87 | 0.120 |
Why?
| Pregnancy Complications | 1 | 2019 | 431 | 0.120 |
Why?
| Informed Consent | 1 | 2015 | 163 | 0.120 |
Why?
| Patient Satisfaction | 1 | 2018 | 585 | 0.120 |
Why?
| Automobile Driving | 1 | 2016 | 129 | 0.120 |
Why?
| Twins, Dizygotic | 3 | 2010 | 182 | 0.120 |
Why?
| Cohort Studies | 6 | 2021 | 4960 | 0.120 |
Why?
| Proteomics | 1 | 2020 | 855 | 0.120 |
Why?
| Practice Patterns, Physicians' | 3 | 2019 | 1182 | 0.120 |
Why?
| Medicine | 1 | 2016 | 104 | 0.120 |
Why?
| Netherlands | 1 | 2014 | 65 | 0.120 |
Why?
| Time Factors | 3 | 2019 | 6182 | 0.120 |
Why?
| Aged | 5 | 2018 | 19292 | 0.110 |
Why?
| Genetic Testing | 1 | 2016 | 383 | 0.110 |
Why?
| Regression Analysis | 3 | 2019 | 960 | 0.110 |
Why?
| Receptors, GABA-A | 1 | 2014 | 88 | 0.110 |
Why?
| Conflict of Interest | 1 | 2014 | 120 | 0.110 |
Why?
| Emotions | 2 | 2021 | 480 | 0.110 |
Why?
| Temperament | 1 | 2013 | 47 | 0.110 |
Why?
| Patient Safety | 1 | 2016 | 276 | 0.110 |
Why?
| Condoms | 1 | 2013 | 113 | 0.110 |
Why?
| Severity of Illness Index | 2 | 2019 | 2590 | 0.100 |
Why?
| Socioeconomic Factors | 2 | 2013 | 1088 | 0.100 |
Why?
| Receptors, Oxytocin | 1 | 2012 | 22 | 0.100 |
Why?
| Family Conflict | 1 | 2012 | 37 | 0.100 |
Why?
| Sexual Partners | 1 | 2013 | 164 | 0.100 |
Why?
| Educational Status | 1 | 2013 | 413 | 0.100 |
Why?
| Family Relations | 1 | 2012 | 87 | 0.100 |
Why?
| Multivariate Analysis | 2 | 2012 | 1443 | 0.100 |
Why?
| Ethanol | 2 | 2012 | 549 | 0.090 |
Why?
| Psychometrics | 3 | 2009 | 615 | 0.090 |
Why?
| Logistic Models | 4 | 2019 | 1863 | 0.090 |
Why?
| Pentachlorophenol | 1 | 1990 | 22 | 0.090 |
Why?
| Dizziness | 1 | 2010 | 70 | 0.090 |
Why?
| Hospitalization | 1 | 2019 | 1764 | 0.090 |
Why?
| Biomarkers | 1 | 2020 | 3474 | 0.090 |
Why?
| Magnetic Resonance Imaging | 2 | 2019 | 3072 | 0.090 |
Why?
| Models, Statistical | 2 | 2010 | 612 | 0.090 |
Why?
| Sample Size | 2 | 2022 | 119 | 0.080 |
Why?
| Suicidal Ideation | 3 | 2021 | 399 | 0.080 |
Why?
| Receptor, Cannabinoid, CB1 | 1 | 2009 | 28 | 0.080 |
Why?
| Models, Theoretical | 1 | 2013 | 520 | 0.080 |
Why?
| Genetic Markers | 2 | 2007 | 336 | 0.080 |
Why?
| Retrospective Studies | 8 | 2021 | 12615 | 0.080 |
Why?
| Taq Polymerase | 2 | 2006 | 10 | 0.080 |
Why?
| Primary Health Care | 1 | 2018 | 1520 | 0.080 |
Why?
| Child Abuse, Sexual | 1 | 2009 | 83 | 0.080 |
Why?
| Emergency Service, Hospital | 1 | 2019 | 1842 | 0.080 |
Why?
| Quality of Life | 1 | 2019 | 2390 | 0.080 |
Why?
| Stress, Psychological | 1 | 2016 | 975 | 0.080 |
Why?
| Environment | 4 | 2012 | 340 | 0.080 |
Why?
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 9 | 0.080 |
Why?
| Methylphenidate | 2 | 2004 | 36 | 0.070 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 17 | 0.070 |
Why?
| Family | 4 | 2016 | 597 | 0.070 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2007 | 65 | 0.070 |
Why?
| Statistics as Topic | 1 | 2008 | 299 | 0.070 |
Why?
| Risk | 2 | 2020 | 829 | 0.070 |
Why?
| Schizophrenia | 2 | 2022 | 418 | 0.070 |
Why?
| 3' Untranslated Regions | 1 | 2007 | 137 | 0.070 |
Why?
| Child of Impaired Parents | 1 | 2006 | 40 | 0.070 |
Why?
| Microsatellite Repeats | 1 | 2006 | 140 | 0.070 |
Why?
| Fathers | 1 | 2006 | 45 | 0.070 |
Why?
| Cheek | 1 | 2006 | 16 | 0.070 |
Why?
| Lysergic Acid Diethylamide | 1 | 2006 | 2 | 0.070 |
Why?
| Poverty | 2 | 2019 | 444 | 0.070 |
Why?
| Social Facilitation | 1 | 2006 | 10 | 0.070 |
Why?
| Sodium Oxybate | 1 | 2006 | 4 | 0.070 |
Why?
| Central Nervous System Stimulants | 2 | 2004 | 140 | 0.070 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 10 | 0.070 |
Why?
| Alcohol-Related Disorders | 1 | 2007 | 110 | 0.070 |
Why?
| Parents | 2 | 2004 | 1208 | 0.070 |
Why?
| Genetics, Population | 1 | 2007 | 204 | 0.070 |
Why?
| Parenting | 1 | 2009 | 256 | 0.070 |
Why?
| Protein Kinase C | 1 | 2007 | 274 | 0.060 |
Why?
| Religion | 1 | 2006 | 66 | 0.060 |
Why?
| Methamphetamine | 1 | 2006 | 52 | 0.060 |
Why?
| Suicide, Attempted | 1 | 2008 | 316 | 0.060 |
Why?
| Beta Rhythm | 1 | 2004 | 10 | 0.060 |
Why?
| Ketamine | 1 | 2006 | 91 | 0.060 |
Why?
| Universities | 1 | 2007 | 341 | 0.060 |
Why?
| Pain Management | 2 | 2019 | 291 | 0.060 |
Why?
| Marriage | 1 | 2004 | 106 | 0.060 |
Why?
| Data Interpretation, Statistical | 3 | 2010 | 325 | 0.050 |
Why?
| Infant | 3 | 2021 | 7992 | 0.050 |
Why?
| Genome, Human | 2 | 2020 | 372 | 0.050 |
Why?
| Drug Tolerance | 1 | 2003 | 79 | 0.050 |
Why?
| Membrane Transport Proteins | 1 | 2003 | 137 | 0.050 |
Why?
| Loneliness | 1 | 2022 | 27 | 0.050 |
Why?
| Europe | 1 | 2022 | 343 | 0.050 |
Why?
| Sensitivity and Specificity | 2 | 2021 | 1725 | 0.050 |
Why?
| Predictive Value of Tests | 2 | 2021 | 1813 | 0.050 |
Why?
| Models, Psychological | 2 | 2016 | 299 | 0.050 |
Why?
| Electroencephalography | 1 | 2003 | 365 | 0.050 |
Why?
| Personality Assessment | 2 | 2013 | 79 | 0.050 |
Why?
| Calibration | 1 | 2021 | 127 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2003 | 433 | 0.050 |
Why?
| Proportional Hazards Models | 2 | 2018 | 1088 | 0.050 |
Why?
| Follow-Up Studies | 2 | 2019 | 4443 | 0.050 |
Why?
| Bayes Theorem | 1 | 2021 | 333 | 0.040 |
Why?
| Polymerase Chain Reaction | 2 | 2014 | 1001 | 0.040 |
Why?
| Bipolar Disorder | 1 | 2022 | 208 | 0.040 |
Why?
| Minnesota | 1 | 2020 | 134 | 0.040 |
Why?
| Interrupted Time Series Analysis | 1 | 2019 | 45 | 0.040 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 85 | 0.040 |
Why?
| Drug Utilization Review | 1 | 2019 | 57 | 0.040 |
Why?
| Dangerous Behavior | 1 | 2018 | 20 | 0.040 |
Why?
| Infant, Small for Gestational Age | 1 | 2019 | 75 | 0.040 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2019 | 137 | 0.040 |
Why?
| Electronic Mail | 1 | 2018 | 54 | 0.040 |
Why?
| Child, Preschool | 2 | 2022 | 9164 | 0.040 |
Why?
| Safety-net Providers | 1 | 2019 | 95 | 0.040 |
Why?
| Factor Analysis, Statistical | 2 | 2010 | 261 | 0.040 |
Why?
| Atmospheric Pressure | 1 | 2017 | 18 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2012 | 390 | 0.040 |
Why?
| Preoperative Period | 1 | 2018 | 103 | 0.040 |
Why?
| Treatment Outcome | 2 | 2019 | 9163 | 0.040 |
Why?
| Limit of Detection | 1 | 2017 | 55 | 0.040 |
Why?
| Epidemics | 1 | 2018 | 70 | 0.040 |
Why?
| Executive Function | 1 | 2021 | 372 | 0.040 |
Why?
| Transcriptome | 1 | 2022 | 742 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2019 | 336 | 0.040 |
Why?
| Postoperative Period | 1 | 2018 | 292 | 0.040 |
Why?
| Gene Expression | 2 | 2016 | 1442 | 0.040 |
Why?
| Psychiatric Status Rating Scales | 2 | 2010 | 485 | 0.030 |
Why?
| Chromosome Mapping | 2 | 2008 | 505 | 0.030 |
Why?
| Cause of Death | 1 | 2018 | 368 | 0.030 |
Why?
| California | 1 | 2017 | 368 | 0.030 |
Why?
| Mortality | 1 | 2018 | 290 | 0.030 |
Why?
| Nicotine | 2 | 2010 | 267 | 0.030 |
Why?
| CD56 Antigen | 1 | 2016 | 34 | 0.030 |
Why?
| Violence | 1 | 2018 | 204 | 0.030 |
Why?
| Quality Control | 1 | 2016 | 150 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2017 | 477 | 0.030 |
Why?
| Sleep | 1 | 2021 | 625 | 0.030 |
Why?
| Anxiety | 1 | 2022 | 854 | 0.030 |
Why?
| Potassium Channels | 1 | 2016 | 121 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2003 | 1405 | 0.030 |
Why?
| Reward | 1 | 2017 | 208 | 0.030 |
Why?
| Heterozygote | 1 | 2016 | 254 | 0.030 |
Why?
| Thoracic Surgical Procedures | 1 | 2016 | 57 | 0.030 |
Why?
| Psychology, Adolescent | 1 | 2015 | 62 | 0.030 |
Why?
| Cell Adhesion Molecules | 1 | 2016 | 169 | 0.030 |
Why?
| Aging | 1 | 2004 | 1635 | 0.030 |
Why?
| Sexually Transmitted Diseases | 1 | 2016 | 154 | 0.030 |
Why?
| Likelihood Functions | 1 | 2015 | 129 | 0.030 |
Why?
| Demography | 1 | 2015 | 264 | 0.030 |
Why?
| Cesarean Section | 1 | 2016 | 169 | 0.030 |
Why?
| Disclosure | 1 | 2014 | 102 | 0.030 |
Why?
| Arsenites | 1 | 1993 | 4 | 0.030 |
Why?
| Arsenic Poisoning | 1 | 1993 | 7 | 0.030 |
Why?
| Risk Assessment | 2 | 2015 | 2992 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 1137 | 0.030 |
Why?
| Chelating Agents | 1 | 1993 | 71 | 0.030 |
Why?
| Cotinine | 1 | 2013 | 69 | 0.030 |
Why?
| Arsenicals | 1 | 1993 | 24 | 0.030 |
Why?
| Gluconeogenesis | 1 | 1993 | 60 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2016 | 416 | 0.030 |
Why?
| Child Behavior | 2 | 2005 | 218 | 0.030 |
Why?
| Students | 1 | 2017 | 503 | 0.030 |
Why?
| Kidney Tubules | 1 | 1993 | 107 | 0.030 |
Why?
| Psychological Theory | 1 | 2013 | 96 | 0.030 |
Why?
| Privacy | 1 | 2012 | 29 | 0.030 |
Why?
| Probability | 1 | 2013 | 295 | 0.030 |
Why?
| Software | 1 | 2016 | 542 | 0.030 |
Why?
| Carrier Proteins | 1 | 2016 | 703 | 0.030 |
Why?
| Pedigree | 1 | 2013 | 474 | 0.020 |
Why?
| Disease Progression | 1 | 2018 | 2423 | 0.020 |
Why?
| Antidotes | 1 | 1993 | 135 | 0.020 |
Why?
| Exercise | 1 | 2021 | 1611 | 0.020 |
Why?
| Attitude of Health Personnel | 1 | 2018 | 991 | 0.020 |
Why?
| Reproducibility of Results | 2 | 2009 | 2807 | 0.020 |
Why?
| Prognosis | 1 | 2018 | 3344 | 0.020 |
Why?
| Pleasure | 1 | 2010 | 18 | 0.020 |
Why?
| Sensation | 1 | 2010 | 46 | 0.020 |
Why?
| Chromatography, Gas | 1 | 1990 | 27 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 1990 | 376 | 0.020 |
Why?
| Membrane Proteins | 1 | 2016 | 1033 | 0.020 |
Why?
| Patient Discharge | 1 | 2016 | 770 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2012 | 391 | 0.020 |
Why?
| Negotiating | 1 | 2009 | 26 | 0.020 |
Why?
| Psychological Tests | 1 | 2010 | 123 | 0.020 |
Why?
| Molecular Structure | 1 | 1990 | 447 | 0.020 |
Why?
| Epistasis, Genetic | 1 | 2009 | 69 | 0.020 |
Why?
| Personality Inventory | 1 | 2009 | 135 | 0.020 |
Why?
| Mouth Mucosa | 1 | 2007 | 80 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 935 | 0.020 |
Why?
| Parent-Child Relations | 1 | 2009 | 236 | 0.020 |
Why?
| Odds Ratio | 1 | 2009 | 968 | 0.020 |
Why?
| Analysis of Variance | 1 | 2009 | 1227 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 754 | 0.020 |
Why?
| Rats | 2 | 1993 | 5035 | 0.020 |
Why?
| Confidence Intervals | 1 | 2006 | 309 | 0.020 |
Why?
| Linear Models | 1 | 2007 | 777 | 0.020 |
Why?
| Reference Values | 1 | 2006 | 745 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 6434 | 0.020 |
Why?
| Research Design | 1 | 2009 | 949 | 0.010 |
Why?
| Frontal Lobe | 1 | 2004 | 139 | 0.010 |
Why?
| Schools | 1 | 2006 | 399 | 0.010 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 40 | 0.010 |
Why?
| Chi-Square Distribution | 1 | 2004 | 501 | 0.010 |
Why?
| Housing | 1 | 2004 | 115 | 0.010 |
Why?
| Family Characteristics | 1 | 2004 | 154 | 0.010 |
Why?
| Attention | 1 | 2004 | 393 | 0.010 |
Why?
| Algorithms | 1 | 2008 | 1494 | 0.010 |
Why?
| Transcription, Genetic | 1 | 2007 | 1317 | 0.010 |
Why?
| DNA | 1 | 2007 | 1357 | 0.010 |
Why?
| Cognition Disorders | 1 | 2003 | 475 | 0.010 |
Why?
| Double-Blind Method | 1 | 2003 | 1664 | 0.010 |
Why?
| Arsenates | 1 | 1993 | 1 | 0.010 |
Why?
| Unithiol | 1 | 1993 | 2 | 0.010 |
Why?
| Dimercaprol | 1 | 1993 | 6 | 0.010 |
Why?
| Succimer | 1 | 1993 | 4 | 0.010 |
Why?
| Arsenic | 1 | 1993 | 37 | 0.010 |
Why?
| Drug Evaluation, Preclinical | 1 | 1993 | 165 | 0.010 |
Why?
| Animals | 2 | 1993 | 32158 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1993 | 399 | 0.010 |
Why?
| In Vitro Techniques | 1 | 1993 | 1044 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 1993 | 2262 | 0.000 |
Why?
| Mice | 1 | 1993 | 15085 | 0.000 |
Why?
|
|
Hopfer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|